inflammatory condition, and improved outcomes occur with early diagnosis, evaluation, and management. The American College of Rheumatology (ACR) has previously published pharmacologic guidelines to aid clinicians and individuals with RA 1 METHODS This guideline follows the ACR guideline development process and ACR policy guiding management of conflicts of interest and disclosures ( https://rheumatology.org/clinical-practiceguidelines https:// onlinelibrary.wiley.com/doi/10.1002/acr.25117